Analysts Set Expectations for Lucid Diagnostics Inc.'s FY2023 Earnings (NASDAQ:LUCD)

Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) – Equities researchers at Cantor Fitzgerald raised their FY2023 EPS estimates for shares of Lucid Diagnostics in a research report issued on Thursday, August 17th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings per share of ($1.14) for the year, up from their […]

Related Keywords

,Blackrock Inc ,Needham Company ,Citadel Advisors ,Nasdaq ,Verition Fund Management ,Cantor Fitzgerald ,Lucid Diagnostics Inc ,Lucid Diagnostics Company Profile ,Lucid Diagnostics ,Free Report ,Lucid Diagnostic ,Diagnostics Stock Down ,Fund Management ,Street Corp ,Get Free Report ,Diagnostics Inc ,Lucid Diagnostics Daily ,Nasdaq Lucd ,Elucd ,Medical ,Earnings Estimates ,